Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

carbidopa

A hydrazine derivative of dopa. Carbidopa is a peripheral dopa decarboxylase inhibitor that is used as an adjunct to levodopa administration to prevent peripheral biosynthesis of levodopa to dopamine, thereby reducing peripheral side effects. Carbidopa does not penetrate the blood brain barrier so that levodopa, after it reaches the brain, can be metabolized to dopamine by dopa decarboxylase where it exerts its effect on dopamine receptors.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:alpha-methyldopahydrazine
US brand name:Lodosyn
Chemical structure:(-)-L-alpha-hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid
benzenepropanoic acid, alpha-hydrazino-3,4-dihydroxy-alpha-methyl-,(S)-
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search